Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL18076243 | 0.94 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL233404 | 0.88 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAA | |
| SCHEMBL6526444 | 0.85 | ALDH1A1 (0.50) | ALDH1A1TSHRNAAA | |
| SCHEMBL21518705 | 0.84 | ALDH1A1 (0.67) | ALDH1A1TSHRNAAA | |
| SCHEMBL3555482 | 0.84 | ALDH1A1 (0.46) | ALDH1A1TSHR | |
| Ethylene Glycol SCHEMBL21352286 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHR | |
| SCHEMBL6535867 | 0.83 | DGKA (0.48) | ALDH1A1TSHR | |
| SCHEMBL12804223 | 0.82 | GSK3A (0.35) | ALDH1A1 | |
| SCHEMBL9565427 | 0.81 | DGKA (0.52) | ALDH1A1TSHR | |
| SCHEMBL6889455 | 0.81 | DGKA (0.52) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5868 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689898-B1 | LONG-ACTING CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) DERIVATIVE | HANMI PHARMACEUTICAL CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| EP-4716755-A1 | RNA PROBING AND AMPLIFICATION METHODS FOR SINGLE CELL ANALYSIS ON FIXED CELLS | Becton, Dickinson and Company (US) | 2026-04-01 | — | — | EP | claimed |
| US-12508298-B2 | Protein complex by use of a specific site of an immunoglobulin fragment for linkage | HANMI PHARM. CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| EP-4667566-A1 | ARGININE DEIMINASE MUTANT, COVALENT DIMER AND CONJUGATE AND USE THEREOF | Peg-Bio Biopharm Co., Ltd. (Chongqing) (CN) | 2025-12-24 | — | — | EP | claimed |
| US-20250295792-A1 | POLYETHYLENE GLYCOL-MODIFIED FORM OF KININ OR DERIVATIVE THEREOF AND PHARMACEUTICAL USE THEREOF | ZONHON BIOPHARMA INSTITUTE, INC. (CN) | 2025-09-25 | — | — | US | claimed |
| US-20250270275-A1 | PHARMACEUTICAL COMPOSITION COMPRISING POLYPEPTIDE | D&D PHARMATECH INC. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250222078-A1 | MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS | HALOZYME, INC. (US) | 2025-07-10 | — | — | US | claimed |
| EP-4582090-A2 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | Polaris Group (TW) | 2025-07-09 | — | — | EP | claimed |
| EP-4580694-A1 | SEALANTS FOR TISSUE CLOSURE | Ethicon, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| US-12338270-B2 | Pharmaceutical composition comprising polypeptide | D&D PHARMATECH INC. (KR) | 2025-06-24 | — | — | US | claimed |
| WO-1998039464-A9 | ADENOVIRUS VECTORS CONTAINING HETEROLOGOUS TRANSCRIPTION REGULATORY ELEMENTS AND METHODS OF USING SAME | — | 1999-02-18 | — | — | WO | claimed |
| WO-1998051784-A1 | MODIIFIED ARGININE DEIMINASE | PHOENIX PHARMACOLOGICS, INC. (US) | 1998-11-19 | — | — | WO | claimed |
| WO-1998039467-A2 | ADENOVIRUS VECTORS SPECIFIC FOR CELLS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF | CALYDON, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998039466-A2 | ADENOVIRUS VECTORS SPECIFIC FOR CELLS EXPRESSING ANDROGEN RECEPTOR AND METHODS OF USE THEREOF | CALYDON, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998039465-A2 | ADENOVIRUS VECTORS SPECIFIC FOR CELLS EXPRESSING ALPHA-FETOPROTEIN AND METHODS OF USE THEREOF | CELL GENESYS, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998039464-A2 | ADENOVIRUS VECTORS CONTAINING HETEROLOGOUS TRANSCRIPTION REGULATORY ELEMENTS AND METHODS OF USING SAME | CELL GENESYS, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1997043645-A1 | ANTIBODIES DIRECTED AGAINST DITHIOCARBAMATES | MEDINOX, INC. (US) | 1997-11-20 | — | — | WO | claimed |
| CN-1126441-A | Amplification of vitamin B12 absorption System Using polymers | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| US-4959309-A | Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays | MOLECULAR DIAGNOSTICS, INC. (US) | 1990-09-25 | — | — | US | claimed |
| US-4166820-A | Selenium compounds | SPALLHOLZ JULIAN E | 1979-09-04 | — | — | US | claimed |